去纤苷在医保范围内吗？

Defibrotide is the first drug approved by the U.S. FDA to treat severe hepatic veno-occlusive disease. It is used for adult or pediatric patients with hepatic venous obstruction (VOD) who have undergone blood or bone marrow hematopoietic stem cell transplantation (HSCT) and are accompanied by renal or lung function abnormalities. The drug has also received "orphan drug" designation. It was first developed by Gentium Pharmaceuticals in Italy and was approved for marketing in the EU in October 2013. It was approved for sale in the United States by the U.S. Food and Drug Administration (FDA) on March 30, 2016.

Defibrotide (also called defibrotide) is a single-chain sodium salt of polydeoxyribose ribonuclease, which has anti-thrombotic, anti-ischemic, anti-inflammatory and fibrinolytic properties. Defibrotide is an adenosine receptor agonist with multiple effects. The adenosine A1/A2 receptors of endothelial cells are involved in the regulation of endothelial cells and the response of endothelial cells to injury. Defibrotide can act on these receptors to produce a variety of downstream effects.

Is it covered by medical insurance? Currently, Defibrotide is not on the market in China, so it will not be included in China’s medical insurance catalog to provide everyone with preferential medical insurance policies. Patients who want to purchase Defibrotide can only go abroad to purchase Defibrotide at their own expense. However, as we all know, the price of original drugs is very expensive, and a lot of manpower and material resources are consumed in the process of purchasing drugs, which puts huge pressure on patients. Therefore, more people choose to purchase drugs overseas to obtain the drugs they need. According to what Medical Companion Travel currently knows, the specification of defibrinoside is 200 mg, and the price is about $21,600. It is more suitable for patients to use for a long time, is high quality and low price, and saves worry and effort. The exchange rate in the market often fluctuates, and the price is not always fixed, but will change with the exchange rate. For more information about defibrotide, please contact Medical Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: